Brad Biggs

QC Analyst, Microbiology

Mr. Biggs received his B.S. in Psychology and Biology from the University of Kentucky in 2010 with a concentration in Psychopharmacology. During Mr. Biggs’ tenure at UK, he worked as a Computing Services Consultant and conducted scientific research which involved investigating the teratogenic effects of Fetal Alcohol Syndrome (FAS) in preclinical trials. Specifically, Mr. Biggs studied the effects of various experimental drugs and their potential use to inhibit memory deficits and hyperactivity caused by FAS using validated research methodology and techniques.

In 2011, Mr. Biggs accepted the position as a laboratory manager in the Department of Anatomical Sciences and Neurobiology at the University of Louisville. He is currently investigating the effects of insulin growth factor receptor (IGFr) and its role in gustatory (taste) development. During this time, Mr. Biggs has set up two laboratories specializing in immunohistochemistry, DNA amplification / genotyping, and RNA quantification. This has allowed him to become proficient in targeted gene analysis and the quantification of gene expression. Furthermore, Mr. Biggs has an extensive knowledge of chemistry and biochemistry especially pertaining to chemical extraction and isolation.

Ongoing responsibilities include procurement and maintenance of laboratory supplies and equipment which has allowed him to develop relationships with many biotechnology distributors and troubleshoot the vast array of problems that can occur during day to day from an operational perspective. Mr. Biggs brings an extensive knowledge of genetic analysis pertaining to pathogen identification and quantification as well as chemotype identification through cannabinoid enzymatic expression as it pertains to selective genetic breeding.

As the extraction operations analyst for Phytosciences, Mr. Biggs works in collaboration with our Director of Clinical Research to design, develop, and coordinate cannabis product Research & Development.